Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
C3 Centre Holding Inc. is a Quebec-based cannabis business accelerator and holding company that operates a large-scale pharmaceutical and cannabis innovation campus in Vaudreuil-Dorion. The 180,000-square-foot facility, formerly a Hoffmann-La Roche complex, serves as an ecosystem for cultivation, extraction, food transformation, research, and education. C3 provides early-stage cannabis and biotech firms with access to R&D labs, production facilities, and capital to accelerate commercialization. In 2023, its affiliate C3 Souvenir Holding acquired Verdélite Sciences and its 88,000-square-foot cultivation facility from Skye Bioscience, further expanding its operational footprint in the Canadian cannabis market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on C3 Centre Holding.